Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma carnitine in alcoholism.

R K Fuller1, C L Hoppel

  • 1Veterans Administration Medical Center, Cleveland, OH 44106.

Alcoholism, Clinical and Experimental Research
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioenergetic functions in subpopulations of heart mitochondria are preserved in a non-obese type 2 diabetes rat model (Goto-Kakizaki).

Scientific reports·2020
Same author

Mitochondria as targets of drug toxicity: Lessons from the R118 phase I experience.

Clinical pharmacology and therapeutics·2015
Same author

Multiple mitochondrial alterations in a case of myopathy.

Ultrastructural pathology·2014
Same author

Mitochondria in the human heart.

Journal of bioenergetics and biomembranes·2009
Same author

A novel mutation in the mitochondrial tRNA(Ser(AGY)) gene associated with mitochondrial myopathy, encephalopathy, and complex I deficiency.

Journal of medical genetics·2006
Same author

Relationship of primary mitochondrial respiratory chain dysfunction to fiber type abnormalities in skeletal muscle.

Clinical genetics·2005
Same journal

COVID-19 pandemic-related changes in utilization of telehealth and treatment overall for alcohol use problems.

Alcoholism, clinical and experimental research·2022
Same journal

The relationship between fathers' heavy episodic drinking and fathering involvement in five Asia-Pacific countries: An individual participant data meta-analysis.

Alcoholism, clinical and experimental research·2022
Same journal

Screening for hazardous alcohol use in the Emergency Department: Comparison of phosphatidylethanol with the Alcohol Use Disorders Identification Test and the Timeline Follow-back.

Alcoholism, clinical and experimental research·2022
Same journal

Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.

Alcoholism, clinical and experimental research·2022
Same journal

College students' virtual and in-person drinking contexts during the COVID-19 pandemic.

Alcoholism, clinical and experimental research·2022
Same journal

Does state repeal of alcohol exclusion laws increase problem drinking?

Alcoholism, clinical and experimental research·2022
See all related articles

Alcoholism alters carnitine homeostasis, leading to elevated plasma long-chain acylcarnitine levels in individuals without liver disease. This finding highlights carnitine

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Nutritional Science

Background:

  • Carnitine is crucial for mitochondrial fatty acid beta-oxidation.
  • Plasma carnitine levels can indicate cellular metabolic changes.
  • Previous studies noted elevated carnitine in alcoholic liver disease.

Purpose of the Study:

  • To investigate plasma carnitine levels in alcoholic patients without overt liver disease.
  • To compare carnitine profiles between alcoholic patients, those with alcoholic liver disease, and healthy controls.

Main Methods:

  • Plasma carnitine concentrations (short-chain and long-chain acylcarnitine) were measured.
  • Measurements were taken in alcoholic patients (n=20), patients with alcoholic liver disease (n=28), and healthy controls (n=32).

Related Experiment Videos

Main Results:

  • Alcoholic patients without liver disease showed significantly elevated plasma long-chain acylcarnitine compared to healthy controls (P < 0.01).
  • These patients also had significantly lower short-chain and long-chain acylcarnitine levels than patients with alcoholic liver disease (P < 0.01).

Conclusions:

  • Alcoholism is associated with altered carnitine homeostasis.
  • Elevated long-chain acylcarnitine in alcoholics suggests a specific metabolic derangement independent of overt liver disease.